Massive New Study Confirms Ivermectin Reduces Mortality by 70% Compared to Expensive Remdesevir

After over 900 studies have proven the effectiveness and safety of Ivermectin, a massive new study was recently published which confirmed the drug is far more efficacious than the much more expensive Remdesevir.

Remdesevir, which is the standard treatment for patients with COVID-19 — and which many healthcare professionals have said is causing severe side effects — costs over $400 on average per vial. Ivermectin in comparison, which has received a lot of criticism from the international media, costs just cents per tablet.

The new study which covers thousands of individuals was taken from 44 healthcare organizations and 68 million patients in the US. The study controlled for comorbidities, obesity, race, ethnicity, age, nicotine use, and other important factors.

The study found that patients using the far cheaper Ivermectin compared to Remdesevir were 70% less likely to die from COVID-19.


Like this post?

Leave a Reply

Your email address will not be published.

Related Posts